Peiting Zeng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Gene Expression

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)